Friday, March 27, 2026

Clinical Relevance of Red Cell Distribution Width and Reticulocytes Hemoglobin Content in Children with Fever without Source

 

Clinical Relevance of Red Cell Distribution Width and Reticulocytes Hemoglobin Content in Children with Fever without Source

Introduction

The main reason to consult in a pediatric emergency service is fever [1]. Up to 20% of these fever episodes have no apparent source in children under 3 years old and represent a specific nosological entity called fever without source (FWS) [2]. FWS represents a frequent and challenging situation, because both the timely distinction between a viral and bacterial etiology, as well as the early identification of individual with benign and selflimiting disease prone to be treated in an ambulatory settings, still remain partially met clinical needs [2,3]. FWS stratification tools include several clinical prediction rules, biological parameters, such as leukocytosis, C-reactive protein (CRP), and procalcitonin (PCT). So far these risk stratifications have been mostly dedicated to distinguish between viral and severe bacterial infections (SBI) with suboptimal discriminant accuracy [4]. If PCT values below 0.3 ng/ml have shown some promise to effectively rule-out SBI [5,6], knowing whether this single biomarker would outperform clinical prediction rules, enhance their discriminate accuracy for SBI or display sufficient negative predictive value (NPV) is still uncertain [3,6]. Considering these limitations, the integration of multiple biomarkers into a biomarker-based score showed some promise. To this respect the Lab-Score combining CRP, PCT, and urine analysis results probably represent the most discriminatory algorithm available so far [2,7-9], especially when used in a step by step approach in combination with clinical presentation, age and absolute neutrophils count, with optimal NPV for SBI [10]. Nevertheless, because of the lack of specific markers for viral infection, approximately 50% of children with FWS of viral etiology are currently exposed to unnecessary antibiotic treatment and are hospitalized [11].

Therefore, the identification of a biomarker highly specific for viral infections or allowing the early distinction between FWS patients with self-limited disease from those requiring hospitalization could be of considerable interest to optimize patient triage at the emergency room. Among emerging biomarkers of possible interest in FWS, several new hematological parameters automatically provided by SysmexTM analyzers could represent appealing candidates [12-16]. Among them, the red blood cell distribution width (RDW-CV) measuring the degree of heterogeneity of erythrocyte volume, and the reticulocytes hemoglobin content (Ret-He) indicating the iron availability for erythropoiesis, may be promising. In adults suffering from Influenza infections or septic shock, RDW-CV elevation was found to be associated with a worse prognosis [12,13]. On the other hand, in community acquired pneumonia, Ret-He has been shown to be decreased transiently in response to the Interleukin6–dependent hepcidin production leading to iron sequestration in other compartments than those involved in red blood cells maturation [14,15]. Whether Ret-He changes could reflect the infection severity or be of clinical relevance especially in infectious settings is still elusive. Therefore, in this pilot study we investigated whether RDW-CV and Ret-He, already available at no additional costs, could provide meaningful diagnostic and prognostic information in FWS when compared to the Lab-score, and whether these parameters would improve the discriminant accuracy of the Lab-score, both in term of hospitalization duration prediction and ability to confirm the presence of a viral infection

Materials and Methods

The research ethics committee of Geneva University Hospitals approved the study protocol (CER 15-082), and Informed consent given by parent or legal representative before enrolment. The study was performed in accordance with the declaration of Helsinki.

Patient Population and Study Design

This ancillary study was derived from a soon published cohort [17]. Participants for this prospective, single-center, and epidemiological diagnostic study were enrolled in the emergency room (ER) division of the Geneva University Hospitals between November 2015 and December 2017. Briefly, 241 patients aged <3 years-old were admitted to the pediatric ER of Geneva University Hospitals (a tertiary care hospital) with a diagnosis of FWS. FWS was defined as a febrile episode of less than 7 days with no cause determined by the history or the physical exam. The exclusion criterias for this study were unavailable blood samples or unavailable SysmexTM datas, comorbidities predisposing to infections such as cancer, primary or secondary immunodeficiency, and iatrogenic immunosuppression. From the initial 241 patients, 170 had to be excluded because of missing RDW-CV and Ret-He data, leaving 71 patients available for this exploratory study (Figure 1). Besides usual blood investigations for the normal care of children presenting with FWS, blood and urine culture were obtained for all patients. Real-time PCR was used for Adenovirus (AdV, quantitative assay, Argene commercial kit) and Herpes Human Virus- 6 (HHV- 6, qualitative assay, in-house assay followed by quantitative assay, Genesig commercial kit) [18], whereas quantitative and semiquantitative, real-time, reverse- transcription (RT)-PCR were used for Hepatitis E virus (HEV) [19] and Human Parechovirus (HPeV) respectively [20]. Semi-quantitative results were reported as cycle threshold (CT) values; samples with CT values <40 were considered positive. Quantitative results were reported in copies/ml (17). Medical history and the Lab-score, were obtained at admission and relevant information was recorded on an individual case report form [17].

Study Endpoints

Two predetermined endpoints were considered for this explorative study. The primary endpoint consisted in hospitalization duration >24h (HD>24h). The secondary endpoint consisted in a final diagnosis of viral infection defined by the identification of aforementioned viral pathogens or in presence of a highly suggestive clinical presentation in absence of documented bacterial infection. Purely bacterial, mixed infections or undefined etiologies were considered as other etiologies. The endpoints adjudication was performed by one senior physician blinded to the participant’s biological data.

Biological Analyses

Venous blood samples were collected in heparinate lithium and Ethylene Di-amino Tetra Acetate (EDTA) vials on patient admission to the pediatric ER, prior to treatment initiation. Samples were immediately processed for routine requirement. PCT and CRP measurements were performed on Cobas 8000 instruments (Roche, module c801 and module c702, respectively).

Generic and Specialized Hematological Parameters

Blood samples were collected in pediatric tubes containing EDTA and then analyzed for CBC-DIFF and reticulocytes count on a Sysmex XN-10 instrument. Besides classical hematological parameters, such as the leucocytes count, hemoglobin concentration and the neutrophils count, the XN-10 provides new parameters delivering complementary information for the granulocytic lineage and the red lineage [16]. We studied 6 of these new parameters. Three for the granulocytic lineage: the Neutrophil Reactive Intensity (NEUT–RI), the Neutrophil Granularity Intensity (NEUTGI) and Neutrophils Width on y axis (NEUT-WY); and 3 for the red lineage: the hemoglobin content of reticulocytes (Ret-He), the difference in cellular hemoglobin content between reticulocytes and erythrocytes (Delta-He) and the Red Cell Distribution Width CV (RDW-CV). Further details regarding these specialized hematological parameters can be found in Figures 1-3.

biomedres-openaccess-journal-bjstr

Figure 1: White blood cells scattergram in the WBC channel. The scattergram in the WBC channel represents on the x axis the structure of the cells (SSC) and on the y axis the fluorescence (SFL). The NEUT-RI represents the mean fluorescence of neutrophils and is related to the activation and the immaturity of the cells. The NEUT-GI represents the mean value of high angle diffraction and represents the complexity of the neutrophils (nucleus, granulations, …) [16]. The red cloud named EO represents eosinophils, the blue cloud named NEUT + BASO represents neutrophils and basophils, the green cloud named MONO represents monocytes, the purple cloud named LYMPH represents lymphocyts.

biomedres-openaccess-journal-bjstr

Figure 2: Red blood cells scattergram in the RET channel. The scattergram in the RET channel represents on the x axis the fluorescence and on the y axis the size of the red blood cells. The Ret– He is calculated from the Ret–Y (mean value of the red blood cell size on the y axis) and represents the mean hemoglobin content of red blood cell precursors (Reticulocytes). The Delta-He is the difference in cellular hemoglobin content between reticulocytes and erythrocytes.

biomedres-openaccess-journal-bjstr

Figure 3: Red Cell Distribution Width Standard Deviation (RDW-SD) and Red Cell Distribution Width Coefficient of Variation (RDW-CV) derived from the red blood cells curve in impedance. The RDW-CV is calculated from the RDW-SD which is the width of the impedance curve of the red blood cells 20% above the base line.

Statistical Analyses

biomedres-openaccess-journal-bjstr

Table 1: Determinant of the Lab-score.

Note: *Positive urine dipstick: positive leukocytes esterase, or nitrite test result. LE: leucocytes; NI: Nitrites.

Analyses were performed using STATISTICA™ software (StatSoft, Tulsa, OK, USA). Fisher’s bilateral exact test and Mann– Whitney U-test were used where appropriate. Associations between biomarkers and study endpoints are presented as the odds ratio (OR) and corresponding 95% confidence interval (95% CI). Multivariable analyses with logistic regression were used to assess associations between continuous variables. In this model, endpoints were set as dependent variables, and the Lab-Score (Table 1) was set as the unique confounder because of the limited sample size. Adjusted analyses were performed only in case of significant univariate analyses. ROC analyses were performed using ANALYSE-IT™ software for Excel (Microsoft, Redmond, WA, USA) to identify the biomarker with the best area under the curve (AUC). AUC comparisons were performed according to the nonparametric approach proposed by DeLong, et al. [21]. The optimal cut-off was determined in a post-hoc based upon ROC curve results. Corresponding sensitivity (SE), specificity (SP), positive predictive value (PPV), negative predictive value (NPV) with the respective 95% CIs are given. A value of p<0.05 was considered statistically significant.

Results

Baseline Clinical Demographic and Biological Characteristics

The clinical features of our population are summarized in Table 2. A total of 71 patients were included in the cohort. Among them 19 were discharged <24 hours, and 38 had a final diagnosis of viral infection. Among the latter, 11 had an enteroviral meningitis (15.5%), 12 a viral upper respiratory tract infections (16.9 %), 12 a viral gastroenteritis (16.9%), 1 a hand-foot-and-mouth disease (1.41%), 1 a viral rash (1.41%), and 1 a viral meningitis (1.41%). The remaining patients included had either bacterial infections only, mixed infections (bacterial and viral) (n=7), or undefined etiologies (n=3). A total of 52 patients had a hospital stay superior or equal to 24 hours (73.24%).

RDW-CV as an Independent Predictor of the Hospitalization Duration >24h (HD >24)

Table 2 shows that patients with HD>24h had higher median levels of RDW-CV upon inclusion when compared to those with HD<24h (14.1% versus 13.1% p<0.0001). The results were further confirmed by the ROC curves analyses (Table 3) showing that the AUC of the RDW-CV for an HD>24h was 0.79 (95%CI:0.67-0.92, p<0.0001), which was the highest for all parameters tested. In comparison, the ROC curve of the Lab-score displayed an AUC of 0.66 (95%CI: 0.53-0.79, p=0.0068). The AUC difference between RDW-CV and the Lab-score was nevertheless not found to be significant according to the Delong method (delta: 0.13, p= 0.11; Table 3). Adding RDW-CV to the Lab-score significantly increased the latter AUC from 0.66 to 0.84 (95CI%: 0.72-0.95; delta: 0.18; p=0.001, Table 3). Furthermore, logistic regression analyses indicated that for each percent of RDW-CV

increase, there was a concomitant 3.28-fold increase in the risk of HD>24h (OR: 3.28, 95%CI:1.57-6.87, p=0.0015) which remained unchanged after the adjustment for the Lab- score (OR: 3.76, 95%CI: 1.11-12.67, p=0.03) (Table 4). Conversely, the risk association for the Lab-score was independent of RDW-CV (adjusted OR: 1.68,95% CI: 1.07 - 2.65; p=0.03). Taken together, these results indicate that both RDW-CV and the Lab-score are independently associated with HD>24h, with an apparent superior strength of association Privileging the PPV, the optimal cut-off of RDW-CV was found to be of 15.2 % with a PPV of 100 % (95%CI: 63-100), a NPV of 31% (95%CI: 20-44), a SN of 17% (95%CI:9-31), and a SP of 100% (95%CI:79-100; Table 5).

biomedres-openaccess-journal-bjstr

Table 2: Patient Baseline Characteristics.

Note: *Correspond to significant AUC differences.

GB: WBC: White Blood Cells; PNN: Neutrophils; IG#: Immature Granulocytes; NRBC: Nucleated Red Blood Cells; GR: RBC : Red blood cells

biomedres-openaccess-journal-bjstr

Table 3: Discriminant accuracies of hematological parameters for hospitalization duration ≥ 24h and infections of viral etiology.

Note: *Correspond to significant AUC differences.

biomedres-openaccess-journal-bjstr

Table 4: Risk associations for hospitalization duration ≥24h.

Note: *Adjusted for the Lab-score, except when **. Adjusted analyses were performed only in case of significant univariate analyses. ** adjusted for RDW-CV. *** adjusted for Labscore and age

biomedres-openaccess-journal-bjstr

Table 5: Optimal cut-off values.

Note: *Based upon ROC curves analyses. **Set in order to maximize PPV.

Ret-He as a Non-Meaningful Marker of Infections of Viral Etiologies

Table 2 shows that patients with a final diagnosis of viral infection had higher median levels of Ret-He upon study inclusion when compared to those with infections of other etiologies (29.9 pg vs 26.25 pg, p=0.004). ROC curves analyses (Table 3) indicated that Ret-He had an AUC of 0.70 (95%CI: 0.57-0.84, p=0.002), whereas the Lab- score (cut-off: 3 points (22)) (displayed the highest diagnostic accuracy with an AUC of 0.88 (95%CI: 0.79- 0.96, p<0.0001) to detect an infection of viral etiology. The AUC comparison between Lab-score and Ret-He, indicated that the AUC difference was significant with a delta of 0.18 and a p-value of 0.047. Logistic regression analyses indicated that if Ret-He was significantly associated with a final diagnosis of viral infection in unadjusted analysis (OR:1.31;95%CI: 1.09-1.57, p=0.004), the association was lost after adjusting for the Lab-score. Furthermore, none of the parameters tested remained significant when adjusted for the Lab-score (Table 6). Privileging the PPV value, the optimal cut-off value found was 29.8 pg with a PPV of 76% (95% CI: 0.53- 0.89), a SP of 81% (95% CI:0.63-0.92), a SN of 53% (95% CI:0.35- 0.70), and NPV of 60% (95% CI: 0.46-0.76; Table 5).

biomedres-openaccess-journal-bjstr

Table 6: Risk associations for infections of viral etiology.

Note: *Adjusted for the Lab-score. Adjusted analyses were performed only in case of significant univariate analyses.

Discussion

The key finding of this pilot study is that both RDW-CV and the Lab-score were independent predictors of a HD>24h in children with FWS, whereas the remaining hematological parameters tested were not, after the adjustment for the Lab-score. To the best of our knowledge, this is the first report of the Lab-score as predictor of hospital duration. Indeed, so far most of the studies performed analyzed the capacity to distinguish patients with SBI [2,7,10,22]. Nevertheless, despite being significant, the AUC was rather modest (0.66) and whether it would be enough to influence patient management remains to be tested in other larger studies. On the other hand, RDW-CV tended to have a better AUC (0.79) and displayed an optimal positive predictive value of 100% at the 15.2% cut-off. Although derived in a post-hoc manner in order to optimize positive predictive value, this cut-off is very close to previously reported RDW-CV cut- offs (between 14.5 % and 15.5%) predicting mortality in patients with SBI or septic shock [12,23- 25]. Furthermore, if the AUC difference between RDW-CV and the Lab- score (0.79 vs 0.66; p=0.13) was not found to be significant according to the Delong method [21], adding RDW-CV to the Labscore nevertheless substantially increased the latter AUC from 0.66 to 0.84 (p=0.001) (Table 6). These results indicate that RDWCV values above 15.2% in FWS would allow the clinicians to early identify patients requiring prolonged hospitalization regardless of infection etiology, and accordingly to improve patients triage in the emergency room.

Furthermore, being automated and available 24h/24h with a turn-around time around 1 minute, RDW-CV results would meet most of the requirements needed for an emergency test. Nevertheless, these appealing preliminary results need to be replicated and validated at a larger scale before any clinical recommendation can be made. Also, knowing whether RDW-CV should be introduced into the Lab-score or considered separately to optimally identify patients requiring hospitalization awaits clarifications. The other principal findings concerning the Ret-He is that this parameter was not significant when adjusted with the Labscore to predict the viral etiology in FWS, as the other parameters tested. However, it is interesting to mention that the median value of Ret-He for viral infections (29.9 pg vs 26.25 pg) was higher than the one retrieved in other etiologies (including bacterial, mixed infections and undefined etiologies), which can be explained by the fact that iron sequestration is more severe in case of septic conditions (26,27). The Ret-He AUC to predict a uniquely viral infection was not found to be optimal (AUC: 0.70), especially as it was not found to be independently associated with this diagnosis, when adjusted for the Lab-score. Furthermore, privileging the PPV, the optimal post-hoc retrieved cut-off (29.8 pg) only displayed a PPV of 76%, which is too low to be considered for rule-in purposes, especially given the lower end of the 95%CI (53%). There are several limitations in this study. Firstly, due to the limited sample size of this pilot study, we could not provide a proper interpretation of non-significant findings reported. Nevertheless, given the strength and independent nature of the association between RDWCV and HD>24h, those preliminary results clearly indicate that RDW-CV could represent an appealing biomarker to early identify FWS patients requiring hospitalization.

A second important limitation resided in the fact that the optimal cut-off for RDW-CV (and Ret-He) was determined in a post-hoc manner. Therefore, the current proposed cut-off would require further independent validation in other larger prospective studies. Finally, the fact that our population exclusively included children where reference intervals for RDW-CV and Ret-He are still undetermined, we could not further extrapolate on the relevance of the proposed cut-offs from adult populations. However, this pilot study opens some new perspectives in the research of new but readily automatically available biomarkers to optimize patient management flux presenting to the ER with FWS.

Conclusion

In conclusion, it appears that the RDW-CV is a good independent predictor of the hospitalization duration superior or equal to 24 hours with an optimal PPV of 100%. Moreover, when added to the Lab-score, the RDW-CV was found to increase the prognostic capacity of the Lab-score, one of the best available risk stratification tools in FWS. When above 15.2% RDW-CV has the potential to help the clinician to early identify FWS patients requiring hospitalization, and as such could facilitate patient management flux in the emergency room. On the other hand, none of the biomarker tested was found to outcompete the Lab-score in distinguishing between fevers of purely viral origin from fevers of other etiologies. Those preliminary findings need to be replicated and validated at a larger and multicenter scale before any clinical recommendation can be done.


For more Articles on: https://biomedres01.blogspot.com/

Appraisal of Target Definition for Management of Paraspinal Ewing Tumors with Modern Radiation Therapy (RT): An Original Article

 

Appraisal of Target Definition for Management of Paraspinal Ewing Tumors with Modern Radiation Therapy (RT): An Original Article

Introduction

Ewing sarcoma, initially described by James Ewing in 1921, may be broadly categorized as a high-grade osteolytic bone tumor which may occur at several localizations throughout the skeleton albeit with a tendency to involve the diaphysis of long bones [1- 11]. Children and adolescents are more frequently affected, and multidisciplinary management is required for improved therapeutic outcomes [3-11]. Radiation therapy (RT) plays a major role in treatment of Ewing sarcoma, and there have been improvements in radiotherapeutic management recently [3-11]. Since younger patients are more commonly diagnosed with Ewing sarcoma, adverse effects of irradiation should be thoroughly considered before radiotherapeutic management. While RT is a viable therapeutic option for a variety of cancers, pediatric patients should be more vigilantly considered for irradiation in view of the toxicity and consequences regarding quality of life. Younger patients still in the process of growing may be negatively affected by adverse irradiation effects. Nevertheless, RT may be utilized as part of multidisciplinary Ewing sarcoma management. Every effort is made to avoid radiation induced toxicity in radiotherapeutic management of Ewing sarcoma. Exploitation of image guided RT (IGRT) techniques, adaptive RT (ART), and improved target definition are among the several considerations for contemporary radiotherapeutic management with an improved toxicity profile. Currently, majority of cancer centers utilize Computed Tomography (CT) simulation for RT planning for Ewing sarcoma. While CT is an effective imaging modality, incorporation of other imaging modalities such as Magnetic Resonance Imaging (MRI) may result in improved target definition for radiotherapeutic management. In this study, we assessed RT target definition for Ewing sarcoma by use of multimodality imaging.

Materials and Methods

Patients receiving RT for Ewing sarcoma were assessed with comparative analysis to explore whether multimodality imaging improves target volume definition, interobserver and intraobserver variations for radiotherapeutic management of Ewing sarcoma. To address this critical issue, we comparatively assessed RT target volume determination by integration of MRI or by CT-simulation images only. Ground truth target volume has been determined for every patient on a collaborative basis by board certified radiation oncologists after detailed assessment, colleague peer review, and consensus for actual treatment and comparison purposes. Included patients had paraspinal Ewing sarcoma, and management with RT was decided after close collaboration and detailed multidisciplinary evaluation on an individual basis. We considered optimal therapeutic approaches and protocols by meticulous evaluation of patient, tumor, and treatment characteristics. Decision making procedure included thorough consideration of lesion sizes, localization and association with critical structures, contemplated outcomes of treatment, patient symptomatology and preferences along with logistical issues. RT delivery has been accomplished by use of Synergy (Elekta, UK) linear accelerator (LINAC) available at our tertiary referral institution. CT-simulation has been individually performed for each patient at the CT-simulator (GE Lightspeed RT, GE Healthcare, Chalfont St. Giles, UK) to acquire high quality RT planning images. Following the CT-simulation procedure, acquired RT planning images were sent to the delineation workstation (SimMD, GE, UK) by use of the network. Structure sets including treatment volumes and critical structures have been meticulously determined. Target volume definition was performed by either the CT-simulation images only or by registered CT and MR images. We conducted a comparative analysis for assessment of target definition by CT only and with incorporation of CT-MR registrationbased imaging to investigate the impact of multimodality imaging.

Results

Patients referred for radiotherapeutic management of paraspinal Ewing sarcoma at the Department of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences have been studied for target volume determination by either CT-only imaging or by CT-MR registration-based imaging in this original study. Evaluated tumor related parameters included lesion size, localization and association with the spinal cord, extent of bony invasion, and other characteristics. Additionally, patient age, symptomatology, performance status, lesion location and association with other critical structures have also been assessed. We considered the reports by American Association of Physicists in Medicine (AAPM) and International Commission on Radiation Units and Measurements (ICRU) in precise RT planning. In view of contemporary guidelines and clinical experience, radiation physicists have generated plans by taking into account relevant critical organ dose constraints. Tissue heterogeneity, electron density, CT number and HU values in CT images have been considered by the radiation physicist in RT planning. A critical objective of RT planning included achieving optimal target volume coverage without violation of critical organ dose constraints. The definition of ground truth target volume has beeen accomplished by board certified radiation oncologists after thorough evaluation, colleague peer review, and consensus. Ground truth target volume has been used for actual treatment and for comparison purposes. Treatment delivery with Synergy (Elekta, UK) LINAC has been performed by incorporation of IGRT techniques including the kilovoltage cone beam CT and electronic digital portal imaging. Ground truth target volume has been found to be identical with CTMR registration-based imaging in this study for radiotherapeutic management of paraspinal Ewing sarcoma.

Discussion

Ewing sarcoma has been initially described by James Ewing in 1921 and may be defined as a high-grade osteolytic bone tumor which may occur at several localizations throughout the skeleton albeit with a tendency to involve the diaphysis of long bones [1-11]. Ewing sarcoma more frequently affects children and adolescents, and improved therapeutic outcomes may be achieved through collaborative multidisciplinary management [3-11]. RT composes a critical weapon in the therapeutic armamentarium for treatment of Ewing sarcoma, and there have been several improvements in radiotherapeutic management lately [3-11]. Given that younger patients are more frequently diagnosed with Ewing sarcoma, thorough consideration of adverse effects is mandatory. RT offers a viable therapeutic option for a variety of cancers, however, pediatric patients should be more vigilantly considered for irradiation in given the risk of toxicity and consequences affecting quality of life. Younger patients still in the process of growing may be more prone to be negatively affected by adverse irradiation effects. Even so, RT may be utilized as part of multidisciplinary Ewing sarcoma management. Every effort should be made to avoid radiation induced toxicity in radiotherapeutic management of Ewing sarcoma. Exploitation of IGRT techniques, ART, and improved target definition are among the several considerations for contemporary radiotherapeutic management with an improved toxicity profile. Multimodality imaging techniques and image fusion methods have clearly contributed to improving target definition for several cancers, and there is now growing body of evidence suggesting the use of multimodality imaging for target definition of several tumors throughout the human body [12-45].

In the meantime, majority of cancer centers utilize CT simulation for RT planning for Ewing sarcoma. CT has been an effective imaging modality, however, incorporation of other imaging modalities such as MRI may result in improved target definition for radiotherapeutic management. In this study, we assessed RT target definition for Ewing sarcoma by use of multimodality imaging and found that target definition is improved by multimodality imaging. Within this context, this study may add to accumulating body of data suggesting improved target volume definition by use of multimodality imaging. Clearly, recent years have witnessed several advances in the spectrum of radiation oncology through the introduction of molecular imaging methods, automatic segmentation techniques, stereotactic RT, intensity modulated RT (IMRT), IGRT, and ART [46-84]. In line with these innovatory advances, accuracy and precision in target volume definition has been a more critical aspect of contemporary radiotherapeutic approaches. From this perspective, we consider that our study may have relevant clinical implications for routinization of multimodality imaging for target volume definition in radiotherapeutic management of paraspinal Ewing sarcoma. In conclusion, this study suggests improved target volume definition for radiotherapeutic management of paraspinal Ewing sarcoma by incorporation of MRI in RT planning procedure. Admittedly, there is need for further supporting evidence.


For more Articles on: https://biomedres01.blogspot.com/

Clinical Relevance of Red Cell Distribution Width and Reticulocytes Hemoglobin Content in Children with Fever without Source

  Clinical Relevance of Red Cell Distribution Width and Reticulocytes Hemoglobin Content in Children with Fever without Source Introduction ...